de Koning HJ - Search Results

1

Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).

Roobol MJ, Kranse R, de Koning HJ, Schröder FH. Roobol MJ, et al. Among authors: de koning hj. Urology. 2004 Feb;63(2):309-13; discussion 313-5. doi: 10.1016/j.urology.2003.09.083. Urology. 2004. PMID: 14972478

2

Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.

de Koning HJ, Boer R, Warmerdam PG, Beemsterboer PM, van der Maas PJ. de Koning HJ, et al. J Natl Cancer Inst. 1995 Aug 16;87(16):1217-23. doi: 10.1093/jnci/87.16.1217. J Natl Cancer Inst. 1995. PMID: 7563167

3

European randomized study of screening for prostate cancer--the Rotterdam pilot studies.

Shröder FH, Damhuis RA, Kirkels WJ, De Koning HJ, Kranse R, Nus HG, Blijenberg BG. Shröder FH, et al. Among authors: de koning hj. Int J Cancer. 1996 Jan 17;65(2):145-51. doi: 10.1002/(SICI)1097-0215(19960117)65:2<145::AID-IJC4>3.0.CO;2-Z. Int J Cancer. 1996. PMID: 8567109 Free article. Clinical Trial.

4

European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies.

Schröder FH, Denis LJ, Kirkels W, de Koning HJ, Standaert B. Schröder FH, et al. Among authors: de koning hj. Cancer. 1995 Jul 1;76(1):129-34. doi: 10.1002/1097-0142(19950701)76:1<129::aid-cncr2820760120>3.0.co;2-1. Cancer. 1995. PMID: 8630864 Clinical Trial.

5

A comparison of disease specific survival of patients who died of and who had newly diagnosed prostate cancer.

Boer R, de Koning HJ, Beemsterboer PM, Warmerdam PG, Schroeder FH. Boer R, et al. Among authors: de koning hj. J Urol. 1997 May;157(5):1768-71; discussion 1771-2. J Urol. 1997. PMID: 9112523

6

Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detection.

Rietbergen JB, Kranse R, Kirkels WJ, De Koning HJ, Schröder FH. Rietbergen JB, et al. Among authors: de koning hj. Br J Urol. 1997 Apr;79 Suppl 2:57-63. doi: 10.1111/j.1464-410x.1997.tb16922.x. Br J Urol. 1997. PMID: 9126071 Clinical Trial. No abstract available.

7

Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round.

van den Akker-van Marle ME, Reep-van den Bergh CM, Boer R, Del Moral A, Ascunce N, de Koning HJ. van den Akker-van Marle ME, et al. Among authors: de koning hj. Int J Cancer. 1997 Nov 14;73(4):464-9. doi: 10.1002/(sici)1097-0215(19971114)73:4<464::aid-ijc2>3.0.co;2-y. Int J Cancer. 1997. PMID: 9389557 Free article.

8

Short-term effects of population-based screening for prostate cancer on health-related quality of life.

Essink-Bot ML, de Koning HJ, Nijs HG, Kirkels WJ, van der Maas PJ, Schröder FH. Essink-Bot ML, et al. Among authors: de koning hj. J Natl Cancer Inst. 1998 Jun 17;90(12):925-31. doi: 10.1093/jnci/90.12.925. J Natl Cancer Inst. 1998. PMID: 9637143

9

PSA screening for prostate cancer: the current controversy.

de Koning HJ, Schröder FH. de Koning HJ, et al. Ann Oncol. 1998 Dec;9(12):1293-6. doi: 10.1023/a:1008428327309. Ann Oncol. 1998. PMID: 9932158 Free article. Review. No abstract available.

10

Advanced prostate cancer: course, care, and cost implications.

Beemsterboer PM, de Koning HJ, Birnie E, van der Maas PJ, Schröder FH. Beemsterboer PM, et al. Among authors: de koning hj. Prostate. 1999 Jul 1;40(2):97-104. doi: 10.1002/(sici)1097-0045(19990701)40:2<97::aid-pros5>3.0.co;2-a. Prostate. 1999. PMID: 10386470

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

486 results

Search Page